Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aznavoorian, S.
Right arrow Articles by Engler, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aznavoorian, S.
Right arrow Articles by Engler, J. A.
[Cancer Research 61, 6264-6275, August 15, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

Membrane Type I-Matrix Metalloproteinase-Mediated Degradation of Type I Collagen by Oral Squamous Cell Carcinoma Cells1

Sadie Aznavoorian, Bryan A. Moore, L. Donita Alexander-Lister, Stephanie L. Hallit, L. Jack Windsor and Jeffrey A. Engler2

Oral Cancer Research Center, Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama, 35294-0005 [S. A., B. A. M., S. L. H., J. A. E.]; Department of Oral Biology, Indiana University, Indianapolis, Indiana, 46202 [L. J. W.]; and Research Genetics, Inc., Huntsville, Alabama 35801 [L. D. A-L.]

Oral squamous cell carcinomas are highly invasive lesions that destroy adjacent tissues and invade bone and muscle, which is most likely the result of matrix metalloproteinase (MMP) activity. We examined three cell lines derived from squamous cell carcinoma of the tongue for their intrinsic capacities to degrade interstitial collagen with the goal of identifying the matrix-degrading enzymes. SCC-25 and SCC-15 cells degrade reconstituted fibrillar type I collagen in the absence of exogenous growth factors or cytokines when seeded as a colony on dried films. Degradation is confined to the subjacent matrix, is enhanced 2–3-fold by phorbol ester, and is strictly MMP-dependent, as it is blocked by BB-94 and tissue inhibitor of metalloproteinases-2 but not by inhibitors of serine and cysteine proteinases. Both cell lines express active (Mr 57,000) membrane type I-MMP (MT1-MMP) on their surfaces, as detected by surface biotinylation and immunoprecipitation. Concomitantly, both cell lines activate endogenous MMP-2 when cultured on type I collagen films, as assessed by zymography. Phorbol ester treatment enhances collagen-induced MMP-2 activation, which is accompanied by the appearance of a surface-labeled Mr 43,000 form of MT1-MMP. Treatment of cells with a synthetic furin inhibitor, which inhibits processing of the MT1-MMP zymogen, blocks collagen degradation. In contrast, CAL 27 cells do not degrade collagen under either basal or phorbol 12-myristate 13-acetate-stimulated conditions. Although proMT1-MMP (Mr 63,000/65,000) is detectable in these cells by immunoblot analysis, they express greatly reduced levels of active MT1-MMP on their surfaces relative to SCC-25 and SCC-15 cells. Correspondingly, CAL 27 cells cultured on collagen express neither latent nor active gelatinases. Immunoblots of lysates and conditioned media revealed the constitutive expression of proMMP-1 and proMMP-13 in all three cell lines. We conclude that in the absence of exogenous growth factors or accessory stromal cells, degradation of interstitial collagen by oral squamous cell carcinoma cells requires a threshold level of active MT1-MMP on cell surfaces.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J.-A. Cho, P. Osenkowski, H. Zhao, S. Kim, M. Toth, K. Cole, A. Aboukameel, A. Saliganan, L. Schuger, R. D. Bonfil, et al.
The Inactive 44-kDa Processed Form of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Enhances Proteolytic Activity via Regulation of Endocytosis of Active MT1-MMP
J. Biol. Chem., June 20, 2008; 283(25): 17391 - 17405.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Abdul-Hussien, R. G.V. Soekhoe, E. Weber, J. H. von der Thusen, R. Kleemann, A. Mulder, J. H. van Bockel, R. Hanemaaijer, and J. H.N. Lindeman
Collagen Degradation in the Abdominal Aneurysm: A Conspiracy of Matrix Metalloproteinase and Cysteine Collagenases
Am. J. Pathol., March 1, 2007; 170(3): 809 - 817.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Osenkowski, S. O. Meroueh, D. Pavel, S. Mobashery, and R. Fridman
Mutational and Structural Analyses of the Hinge Region of Membrane Type 1-Matrix Metalloproteinase and Enzyme Processing
J. Biol. Chem., July 15, 2005; 280(28): 26160 - 26168.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
E. L. Rosenthal, W. Zhang, M. Talbert, K. P. Raisch, and G. E. Peters
Extracellular Matrix Metalloprotease Inducer-Expressing Head and Neck Squamous Cell Carcinoma Cells Promote Fibroblast-Mediated Type I Collagen Degradation In vitro
Mol. Cancer Res., April 1, 2005; 3(4): 195 - 202.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. D. Andl, T. Mizushima, K. Oyama, M. Bowser, H. Nakagawa, and A. K. Rustgi
EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes
Am J Physiol Gastrointest Liver Physiol, December 1, 2004; 287(6): G1227 - G1237.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. H.N. Lindeman, R. Hanemaaijer, A. Mulder, P.D. S. Dijkstra, K. Szuhai, D. Bromme, J. H. Verheijen, and P. C.W. Hogendoorn
Cathepsin K Is the Principal Protease in Giant Cell Tumor of Bone
Am. J. Pathol., August 1, 2004; 165(2): 593 - 600.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Zhao, M. M. Bernardo, P. Osenkowski, A. Sohail, D. Pei, H. Nagase, M. Kashiwagi, P. D. Soloway, Y. A. DeClerck, and R. Fridman
Differential Inhibition of Membrane Type 3 (MT3)-Matrix Metalloproteinase (MMP) and MT1-MMP by Tissue Inhibitor of Metalloproteinase (TIMP)-2 and TIMP-3 Regulates Pro-MMP-2 Activation
J. Biol. Chem., March 5, 2004; 279(10): 8592 - 8601.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Guo and L. Piacentini
Type I Collagen-induced MMP-2 Activation Coincides with Up-regulation of Membrane Type 1-Matrix Metalloproteinase and TIMP-2 in Cardiac Fibroblasts
J. Biol. Chem., November 21, 2003; 278(47): 46699 - 46708.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. G. Munshi, Y. I. Wu, E. V. Ariztia, and M. S. Stack
Calcium Regulation of Matrix Metalloproteinase-mediated Migration in Oral Squamous Cell Carcinoma Cells
J. Biol. Chem., October 25, 2002; 277(44): 41480 - 41488.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Tam, Y. I. Wu, G. S. Butler, M. S. Stack, and C. M. Overall
Collagen Binding Properties of the Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Hemopexin C Domain. THE ECTODOMAIN OF THE 44-kDa AUTOCATALYTIC PRODUCT OF MT1-MMP INHIBITS CELL INVASION BY DISRUPTING NATIVE TYPE I COLLAGEN CLEAVAGE
J. Biol. Chem., October 4, 2002; 277(41): 39005 - 39014.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.